These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 29364302

  • 21. Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice.
    Veiga FMS, Graus-Nunes F, Rachid TL, Barreto AB, Mandarim-de-Lacerda CA, Souza-Mello V.
    Biochimie; 2017 Sep; 140():106-116. PubMed ID: 28711683
    [Abstract] [Full Text] [Related]

  • 22. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ, Shi L, Song GY, Zhang HF, Hu ZJ, Wang C, Zhang DH.
    Eur J Pharmacol; 2013 Aug 15; 714(1-3):89-95. PubMed ID: 23791610
    [Abstract] [Full Text] [Related]

  • 23. Short-term strength training reduces gluconeogenesis and NAFLD in obese mice.
    Pereira RM, Rodrigues KCDC, Anaruma CP, Sant'Ana MR, de Campos TDP, Gaspar RS, Canciglieri RDS, de Melo DG, Mekary RA, da Silva ASR, Cintra DE, Ropelle ER, Pauli JR, de Moura LP.
    J Endocrinol; 2019 Apr 01; 241(1):59-70. PubMed ID: 30878016
    [Abstract] [Full Text] [Related]

  • 24. Extracts from Aralia elata (Miq) Seem alleviate hepatosteatosis via improving hepatic insulin sensitivity.
    Hwang KA, Hwang YJ, Kim GR, Choe JS.
    BMC Complement Altern Med; 2015 Oct 05; 15():347. PubMed ID: 26438035
    [Abstract] [Full Text] [Related]

  • 25. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
    Zhang Y, Cui Y, Wang XL, Shang X, Qi ZG, Xue J, Zhao X, Deng M, Xie ML.
    Cytokine; 2015 Sep 05; 75(1):127-35. PubMed ID: 26194065
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Interval aerobic training combined with strength-endurance exercise improves metabolic markers beyond caloric restriction in Zucker rats.
    Aparicio VA, Coll-Risco I, Camiletti-Moirón D, Nebot E, Martínez R, López-Jurado M, Aranda P.
    Nutr Metab Cardiovasc Dis; 2016 Aug 05; 26(8):713-21. PubMed ID: 26874906
    [Abstract] [Full Text] [Related]

  • 28. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
    Zhao L, Cang Z, Sun H, Nie X, Wang N, Lu Y.
    BMC Endocr Disord; 2017 Feb 28; 17(1):13. PubMed ID: 28241817
    [Abstract] [Full Text] [Related]

  • 29. Betaine prevented fructose-induced NAFLD by regulating LXRα/PPARα pathway and alleviating ER stress in rats.
    Ge CX, Yu R, Xu MX, Li PQ, Fan CY, Li JM, Kong LD.
    Eur J Pharmacol; 2016 Jan 05; 770():154-64. PubMed ID: 26593707
    [Abstract] [Full Text] [Related]

  • 30. Diazoxide enhances basal metabolic rate and fat oxidation in obese Zucker rats.
    Alemzadeh R, Karlstad MD, Tushaus K, Buchholz M.
    Metabolism; 2008 Nov 05; 57(11):1597-607. PubMed ID: 18940400
    [Abstract] [Full Text] [Related]

  • 31. Anti-diabetic effects of mildronate alone or in combination with metformin in obese Zucker rats.
    Liepinsh E, Skapare E, Svalbe B, Makrecka M, Cirule H, Dambrova M.
    Eur J Pharmacol; 2011 May 11; 658(2-3):277-83. PubMed ID: 21371472
    [Abstract] [Full Text] [Related]

  • 32. Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-α activation.
    Shi L, Shi L, Zhang H, Hu Z, Wang C, Zhang D, Song G.
    Mol Med Rep; 2013 Aug 11; 8(2):439-45. PubMed ID: 23754536
    [Abstract] [Full Text] [Related]

  • 33. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
    Zhang R, Yu Y, Hu S, Zhang J, Yang H, Han B, Cheng Y, Luo X.
    Nutr Res; 2016 Sep 11; 36(9):1022-1030. PubMed ID: 27632923
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Genistein has beneficial effects on hepatic steatosis in high fat-high sucrose diet-treated rats.
    Liu H, Zhong H, Yin Y, Jiang Z.
    Biomed Pharmacother; 2017 Jul 11; 91():964-969. PubMed ID: 28514835
    [Abstract] [Full Text] [Related]

  • 36. Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stress.
    Pai SA, Munshi RP, Panchal FH, Gaur IS, Mestry SN, Gursahani MS, Juvekar AR.
    Biomed Pharmacother; 2019 Mar 11; 111():686-694. PubMed ID: 30611993
    [Abstract] [Full Text] [Related]

  • 37. Effects of cevoglitazar, a dual PPARalpha/gamma agonist, on ectopic fat deposition in fatty Zucker rats.
    Laurent D, Gounarides JS, Gao J, Boettcher BR.
    Diabetes Obes Metab; 2009 Jun 11; 11(6):632-6. PubMed ID: 19175377
    [Abstract] [Full Text] [Related]

  • 38. Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD.
    Pathil A, Liebisch G, Okun JG, Chamulitrat W, Schmitz G, Stremmel W.
    Eur J Clin Invest; 2015 Sep 11; 45(9):925-31. PubMed ID: 26108973
    [Abstract] [Full Text] [Related]

  • 39. Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes.
    Tutunchi H, Ostadrahimi A, Saghafi-Asl M, Hosseinzadeh-Attar MJ, Shakeri A, Asghari-Jafarabadi M, Roshanravan N, Farrin N, Naemi M, Hasankhani M.
    Pharmacol Res; 2020 Jun 11; 156():104770. PubMed ID: 32217148
    [Abstract] [Full Text] [Related]

  • 40. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.
    Milić S, Lulić D, Štimac D.
    World J Gastroenterol; 2014 Jul 28; 20(28):9330-7. PubMed ID: 25071327
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.